Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 2/3 1Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Oropharyngeal Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Sarcoma, Ewing 1Renal Pelvis and Ureter Urothelial Carcinoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Nasopharyngeal Carcinoma 1Muscle Invasive Bladder Urothelial Carcinoma 1Mouth Neoplasms 1Melanoma 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lymphoid Interstitial Pneumonia 1Leukemia, Myeloid, Acute 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Extensive Stage Lung Small Cell Carcinoma 1Carcinoma, Squamous Cell 1Carcinoma 1Adenocarcinoma of Lung 1Adenocarcinoma Of Esophagus 1

Interventions

regorafenib 1Vincristine 1Triptorelin Pamoate 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy 1Radiation 1Magnetic Resonance Spectroscopy 1Irinotecan 1Ifosfamide 1Fluorodeoxyglucose F18 1Etoposide 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Sarcoma, Ewing × Specimen Handling × Clear all
NCT06820957 2026-02-17

Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body

Children's Oncology Group

Phase 2/3 Active not recruiting
437 enrolled
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡